Bioequivalence Study of Two Formulations of Pramipexole Tablets 0.25 mg
NCT02660060
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
23
Enrollment
INDUSTRY
Sponsor class
Conditions
Healthy
Interventions
DRUG:
Pramipexole Dexa Medica
DRUG:
Pramipexole Boehringer Ingelheim Pharma
Sponsor
Dexa Medica Group